, Tracking Stock Market Picks
Enter Symbol:
Crocs, Inc. (CROX) [hlAlert]

up 11.41 %

Crocs, Inc. (CROX) rated Buy with price target $17 by Wunderlich

Posted on: Wednesday,  Oct 1, 2014  8:25 AM ET by Wunderlich

Wunderlich rated Buy Crocs, Inc. (NASDAQ: CROX) on 10/01/2014, when the stock price was $12.70. Since
then, Crocs, Inc. has gained 11.42% as of 01/13/2016's recent price of $14.15.
If you would have followed this Wunderlich's recommendation on CROX, you would have gained 11.41% of your investment in 469 days.

Crocs, Inc. is a rapidly growing designer, manufacturer and marketer of footwear for men, women and children under the CROCS brand. All of the Company's footwear products incorporate its proprietary closed-cell resin material, which the Company believes represents a substantial innovation in footwear comfort and functionality. The Company's proprietary closed-cell resin, which it refers to as Croslite enables Crocs to produce a soft and lightweight, non-marking, slip and odor-resistant shoe. These unique properties make the Company's footwear ideal for casual wear, as well as for recreational uses such as boating, hiking, fishing and gardening, and have enabled Crocs to successfully market its products to a broad range of consumers.

Advising private clients is a long-term and relationship-guided process. The Financial Advisors at Wunderlich Securities recognize that serving individuals and families requires an understanding of their individual goals and needs. Our approach involves a cycle of service. Wunderlich's Financial Advisors work with each client to design, implement and monitor a plan that serves the client's needs. We utilize a variety of high-quality investments including stocks, bonds, mutual funds, options and annuities to build diversified and balanced portfolios.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/1/2014 8:25 AM Buy
12.70 17.00
as of 10/17/2014
1 Week up  2.54 %
1 Month down  -4.72 %
3 Months   
1 YTD down  -4.72 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy